Found 54 articles for: "COVID-19"
Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination
January 2026 | Volume 25 | Issue 1 | Case Reports | 93 | Copyright © January 2026
Background: Although drugs are a common cause of hyperpigmentation, the pathogenesis is unclear and varies based on the offending agent. Classic medications associated with hyper...
Read MorePost-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
September 2025 | Volume 24 | Issue 9 | Case Reports | 938 | Copyright © September 2025
Background: Alopecia universalis (AU) is the most severe form of alopecia areata (AA), characterized by complete scalp and body hair loss. While post-COVID-19 hair loss is often ...
Read MoreIncreasing Concern Over the Cost of Facial Cosmetic Dermatological Procedures Since the Onset of COVID-19
September 2025 | Volume 24 | Issue 9 | Features | 940 | Copyright © September 2025
COVID-19 Protection Strategies: Lessons Learned About Epidermal Barrier Function and the Significance of Optimized Skin Care
April 2024 | Volume 23 | Issue 4 | Original Article | 244 | Copyright © April 2024
Initially categorized as primarily a respiratory disease, COVID-19 can involve other organ systems and may have direct skin manifestations, including exanthems, morbilliform eruption, generalized...
Read MoreTeledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19
February 2024 | Volume 23 | Issue 2 | Editorials | e64 | Copyright © February 2024
Background: During the global COVID-19 pandemic, dermatologists increasingly adopted teledermatology to facilitate patient care.Objective: To identi...
Read MoreHome Is Where the Match Is: Mentorship and Dermatology Residency Match Trends Before and During the COVID-19 Pandemic
December 2023 | Volume 22 | Issue 12 | Editorials | e44 | Copyright © December 2023
Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects
December 2023 | Volume 22 | Issue 12 | Editorials | e42 | Copyright © December 2023
Actemra (tocilizumab) received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19) in June 2021. Literature has linked numerous cutaneous adverse effects to tocil...
Read MoreAntimalarials are not Effective as Pre-Exposure Prophylaxis for COVID-19: A Retrospective Matched Control Study
August 2023 | Volume 22 | Issue 8 | Editorials | 840 | Copyright © August 2023
The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine. While antima...
Read MoreCharacteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity
January 2023 | Volume 22 | Issue 1 | Editorials | 101 | Copyright © January 2023
Background: Studies suggest potential heterogeneity in telemedicine adoption with potential to exacerbate healthcare access inequity.
Methods: A pre-validated s...
Read MoreA Case of Successful Management of Adult-Onset Linear IgA Bullous Disease With Sulfasalazine During the COVID-19 Pandemic
December 2022 | Volume 21 | Issue 12 | Case Reports | 1355 | Copyright © December 2022
Linear IgA bullous disease (LABD) is a rare, acquired, autoimmune, pruritic, and blistering skin condition. Dapsone is a first line treatment option, however, there are limited options if this fails, ...
Read MoreComparison of Pediatric Dermatology Conditions Across Telehealth and In-Person Visits During the COVID-19 Pandemic
November 2022 | Volume 21 | Issue 11 | Features | 1260 | Copyright © November 2022
Understanding the utility of virtual visits in pediatric dermatology practice has become increasingly important in the telehealth era. We compared the conditions diagnosed in pediatric dermatology bet...
Read MoreBlue Light and Skin Health
September 2022 | Volume 21 | Issue 9 | Original Article | 962 | Copyright © September 2022
Although blue light has been present in our lives for decades, this type of visible light has recently become a topic of significant interest as we shift to a greater percentage of our time spent in f...
Read MoreThe Incidence and Risk of Respiratory Tract Infections in Patients Using Biologics for Hidradenitis Suppurativa: A Systematic Review and Meta-analysis
August 2022 | Volume 21 | Issue 8 | Original Article | 819 | Copyright © August 2022
Background: Patients treated with biological therapy for hidradenitis suppurativa (HS) are at an increased risk of infectious complications. However, it is unclear whether these patie...
Read More"I'm Off My Meds": Public Perception of Interactions Between SARS-CoV-2 Vaccines and Anti-Psoriatic Treatments Online
August 2022 | Volume 21 | Issue 8 | Features | 901 | Copyright © August 2022
Importance: Psoriasis patients may seek information about the SARS-CoV-2 vaccine and their diagnosis from social media platforms. Analyses of social media interactions may help guide dermatologists&rs...
Read MoreTeledermatology and Skin of Color Patients
July 2022 | Volume 21 | Issue 7 | Editorials | 793 | Copyright © July 2022
The COVID-19 pandemic popularized telemedicine for many medical systems around the world. Although it came with many advantages for some individuals, it created challenges for other populations, parti...
Read MoreRetrospective Study of Covid Related Hair Loss
July 2022 | Volume 21 | Issue 7 | Original Article | 724 | Copyright © July 2022
The Novel Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus two and primarily affects the epithelium of the airways. Multiple cutaneous manifestations of COVID-...
Read MoreShoreline Nails: A New Nail Sign of SARS-CoV-2 Infection
May 2022 | Volume 21 | Issue 5 | Case Reports | 521 | Copyright © May 2022
With the onset of the SARS-CoV-2 pandemic, a number of nail unit changes have been associated with SARS-CoV-2 infection. We report a new unique nail finding within one month of infection and RT-PCR te...
Read MoreCalcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study
May 2022 | Volume 21 | Issue 5 | Original Article | 481 | Copyright © May 2022
Background: Soft tissue augmentation with calcium hydroxylapatite (CaHA) is a versatile technique for line filling, skin tightening, lifting, contouring, and volumizing. The present s...
Read MoreImpact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey
May 2022 | Volume 21 | Issue 5 | Editorials | 545 | Copyright © May 2022
Background: At the onset of the COVID-19 pandemic, many Mohs micrographic surgeries (MMS) were delayed over concerns for propagating further infectious spread and scarcity of medic...
Read MoreDisparities in Telemedicine Satisfaction Among Older and Non-White Dermatology Patients: A Cross-Sectional Study
February 2022 | Volume 21 | Issue 2 | Editorials | 210 | Copyright © February 2022
Telemedicine use has expanded rapidly during the COVID-19 pandemic. There is limited data on patient satisfaction with teledermatology; therefore, we examined patient teledermatology experiences at a ...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
